Stocks · News reference
Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wall Street analysts changed outlook on top names. For full changes, see our analyst ratings page. Analysts have mixed opinions on SCHW stock.
Read original at benzingaBTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.
Read original at benzingaTD Cowen analyst Stacy Ku initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating.
Read original at benzinga